Purchase Order 75N91019P00770
Award Date 9/12/19
Potential Completion Date 9/18/20
Potential Value $13K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $24,898.13 on August 30, 2018, with ultimate completion on August 29, 2019. No set-aside category applied. Place of performance is Bethesda, Maryland. The purchase order uses fixed-price pricing with economic price adjustment. Life Technologies operates as Thermo Fisher Scientific and supplies laboratory instrumentation, reagents, and consumables to federal research and diagnostic programs.</p>
- The National Cancer Institute awarded a $19,905 firm fixed-price purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on December 2, 2024, with an ultimate completion date of November 1, 2025. This contract is part of the FY26 UDO Initiative and was issued without set-aside designation, reflecting open competitive procurement. Life Technologies Corporation, headquartered in Carlsbad, California, is a leading supplier of scientific instrumentation, reagents, and...
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,960 on July 19, 2017, for laboratory supplies, with an ultimate completion date of August 17, 2017. The order is firm fixed price with no set-aside applied. Place of performance is Carlsbad, California. Life Technologies, operating as Thermo Fisher Scientific, manufactures laboratory instrumentation, reagents, and consumables supplied across federal research and diagnostic sectors.</p>
- The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $14,599.10 on July 18, 2017, for laboratory supplies with an ultimate completion date of August 17, 2017. The order is firm fixed price with no set-aside applied. Place of performance is Carlsbad, California. Life Technologies, operating as Thermo Fisher Scientific, supplies laboratory instrumentation, reagents, and consumables to federal research and diagnostic programs across the life sciences...
- The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,478.46 on May 23, 2019, for drugs and biologicals with an ultimate completion date of June 23, 2019. Work is performed in Grand Island, New York. The order is firm fixed price with no small business set-aside. Life Technologies, a wholly owned subsidiary of Thermo Fisher Scientific, supplies specialized biomedical research instruments, reagents, and consumables to federal agencies as a prime...
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $5,611.84 on July 11, 2017, with ultimate completion on August 16, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order is for laboratory instrumentation, reagents, consumables, or maintenance services typical of Life Technologies' federal portfolio in life-sciences research and diagnostic infrastructure. Pricing is firm fixed price.</p>
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>
- <p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $20,776.50 on September 5, 2019, with completion by October 5, 2019. Place of performance is Carlsbad, California. The order represents a firm fixed-price, commercial purchase of laboratory instrumentation, reagents, or consumables—Life Technologies' core federal offering in genetic analysis and molecular biology. No set-aside was applied.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a one-year, firm fixed price purchase order valued at approximately $15,630 to Life Technologies Corporation. Life Technologies, a subsidiary of Thermo Electron Corporation Financial Services Division, will provide products and services to support the National Cancer Institute's research efforts. No additional details were provided on the specific goods or services requested under the...
- The National Cancer Institute awarded a $18.72K firm fixed price service agreement to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on April 20, 2020, with performance completed by April 28, 2021. The contract was awarded as a blanket purchase agreement (BPA) call without set-aside designation to the Bethesda, Maryland-based vendor. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation, is a leading supplier of scientific instruments, reagents,...